25 XP   0   0   10

Starlake Bioscience Co Inc Zhaoqing Guangdong
Buy, Hold or Sell?

Let's analyse Starlake together

PenkeI guess you are interested in Starlake Bioscience Co Inc Zhaoqing Guangdong. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Starlake Bioscience Co Inc Zhaoqing Guangdong. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Starlake Bioscience Co Inc Zhaoqing Guangdong

I send you an email if I find something interesting about Starlake Bioscience Co Inc Zhaoqing Guangdong.

Quick analysis of Starlake (30 sec.)










What can you expect buying and holding a share of Starlake? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
72.5%

What is your share worth?

Current worth
¥4.48
Expected worth in 1 year
¥7.84
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
¥3.64
Return On Investment
64.4%

For what price can you sell your share?

Current Price per Share
¥5.66
Expected price per share
¥5.38 - ¥5.9
How sure are you?
50%

1. Valuation of Starlake (5 min.)




Live pricePrice per Share (EOD)

¥5.66

Intrinsic Value Per Share

¥18.12 - ¥48.30

Total Value Per Share

¥22.60 - ¥52.78

2. Growth of Starlake (5 min.)




Is Starlake growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$249.6m$738.1m74.7%

How much money is Starlake making?

Current yearPrevious yearGrowGrow %
Making money$33.8m$4.9m$28.8m85.3%
Net Profit Margin3.6%10.4%--

How much money comes from the company's main activities?

3. Financial Health of Starlake (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#60 / 1007

Most Revenue
#10 / 1007

Most Profit
#33 / 1007

Most Efficient
#145 / 1007

What can you expect buying and holding a share of Starlake? (5 min.)

Welcome investor! Starlake's management wants to use your money to grow the business. In return you get a share of Starlake.

What can you expect buying and holding a share of Starlake?

First you should know what it really means to hold a share of Starlake. And how you can make/lose money.

Speculation

The Price per Share of Starlake is ¥5.66. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Starlake.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Starlake, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.48. Based on the TTM, the Book Value Change Per Share is ¥0.84 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Starlake.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.4%0.020.4%0.000.1%0.010.1%0.000.1%
Usd Book Value Change Per Share0.020.4%0.122.0%0.000.0%0.030.5%0.010.2%
Usd Dividend Per Share0.000.1%0.010.2%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.4%0.132.2%0.000.0%0.030.5%0.010.2%
Usd Price Per Share0.73-0.79-0.86-0.71-0.67-
Price to Earnings Ratio8.41-14.33-81.84-77.08-66.72-
Price-to-Total Gains Ratio29.16-36.63--593.71-23.34-76.43-
Price to Book Ratio1.17-1.32-5.72-4.47-5.70-
Price-to-Total Gains Ratio29.16-36.63--593.71-23.34-76.43-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.781646
Number of shares1279
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share0.120.03
Usd Total Gains Per Share0.130.03
Gains per Quarter (1279 shares)160.9237.43
Gains per Year (1279 shares)643.68149.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15159363412138140
21011186127823276290
31521779192235414440
42032372256646552590
52532965321058691740
63043558385470829890
735541514498819671040
8405474451429311051190
94565337578610412431340
105075930643011613811490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%27.00.013.067.5%67.00.020.077.0%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%27.013.00.067.5%58.029.00.066.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%29.00.011.072.5%59.00.028.067.8%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%28.012.00.070.0%63.024.00.072.4%

Fundamentals of Starlake

About Starlake Bioscience Co Inc Zhaoqing Guangdong

Star Lake Bioscience Co., Inc. engages in the manufacture and sale of pharmaceutical raw materials, and food and feed additives under the Star Lake and Yue Bao brand names in China and internationally. The company offers L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; guanosine that is used as an intermediate for food and pharmaceutical raw material; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroying Hepatitis B virus DNA; and L-threonine that is used in premixtures, and pig and poultry feed. It also provides disodium 5'-ribonucleotide to cure chronic hepatitis, muscular atrophy, and eye diseases; disodium 5-inosinate to cure leukopenia, thrombocytopenia, and chronic and acute hepatitis; and inosine, which is used for the treatment of chronic hepatitis, heart disease, leukopenia or thrombocytopenia, central choroidoretinitis, etc. In addition, the company offers disodium 5'-guanylate for canned and salted meat, ham, etc. Further, it provides ribavirin, adenosine, adenine, memantine hydrochloride, arginine, D-ribose, fructose syrup, L-valine, L-threonine, L-lysine, etc. Star Lake Bioscience Co., Inc. was founded in 1964 and is based in Zhaoqing, China.

Fundamental data was last updated by Penke on 2024-04-17 10:57:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Starlake Bioscience Co Inc Zhaoqing Guangdong.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Starlake earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Starlake to the Biotechnology industry mean.
  • A Net Profit Margin of 5.8% means that ¥0.06 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Starlake Bioscience Co Inc Zhaoqing Guangdong:

  • The MRQ is 5.8%. The company is making a profit. +1
  • The TTM is 3.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.8%TTM3.6%+2.2%
TTM3.6%YOY10.4%-6.8%
TTM3.6%5Y9.9%-6.3%
5Y9.9%10Y6.7%+3.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.8%-207.2%+213.0%
TTM3.6%-218.5%+222.1%
YOY10.4%-282.4%+292.8%
5Y9.9%-432.2%+442.1%
10Y6.7%-593.8%+600.5%
1.1.2. Return on Assets

Shows how efficient Starlake is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Starlake to the Biotechnology industry mean.
  • 1.9% Return on Assets means that Starlake generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Starlake Bioscience Co Inc Zhaoqing Guangdong:

  • The MRQ is 1.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.9%TTM1.6%+0.3%
TTM1.6%YOY1.5%+0.1%
TTM1.6%5Y1.5%+0.1%
5Y1.5%10Y0.9%+0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9%-13.2%+15.1%
TTM1.6%-12.6%+14.2%
YOY1.5%-11.5%+13.0%
5Y1.5%-13.7%+15.2%
10Y0.9%-15.5%+16.4%
1.1.3. Return on Equity

Shows how efficient Starlake is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Starlake to the Biotechnology industry mean.
  • 3.5% Return on Equity means Starlake generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Starlake Bioscience Co Inc Zhaoqing Guangdong:

  • The MRQ is 3.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.5%TTM3.5%+0.0%
TTM3.5%YOY2.0%+1.5%
TTM3.5%5Y2.4%+1.1%
5Y2.4%10Y1.5%+0.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5%-16.7%+20.2%
TTM3.5%-15.8%+19.3%
YOY2.0%-14.4%+16.4%
5Y2.4%-19.0%+21.4%
10Y1.5%-19.9%+21.4%

1.2. Operating Efficiency of Starlake Bioscience Co Inc Zhaoqing Guangdong.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Starlake is operating .

  • Measures how much profit Starlake makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Starlake to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Starlake Bioscience Co Inc Zhaoqing Guangdong:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.7%-3.7%
TTM3.7%YOY11.9%-8.2%
TTM3.7%5Y10.4%-6.7%
5Y10.4%10Y5.6%+4.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.5%+286.5%
TTM3.7%-229.1%+232.8%
YOY11.9%-288.4%+300.3%
5Y10.4%-480.7%+491.1%
10Y5.6%-624.7%+630.3%
1.2.2. Operating Ratio

Measures how efficient Starlake is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.77 means that the operating costs are ¥1.77 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Starlake Bioscience Co Inc Zhaoqing Guangdong:

  • The MRQ is 1.775. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.790. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.775TTM1.790-0.016
TTM1.790YOY1.597+0.194
TTM1.7905Y1.613+0.177
5Y1.61310Y1.259+0.354
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7753.231-1.456
TTM1.7903.307-1.517
YOY1.5973.774-2.177
5Y1.6135.667-4.054
10Y1.2597.558-6.299

1.3. Liquidity of Starlake Bioscience Co Inc Zhaoqing Guangdong.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Starlake is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.88 means the company has ¥0.88 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Starlake Bioscience Co Inc Zhaoqing Guangdong:

  • The MRQ is 0.884. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.873. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.884TTM0.873+0.012
TTM0.873YOY2.255-1.383
TTM0.8735Y1.557-0.684
5Y1.55710Y0.850+0.707
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8843.890-3.006
TTM0.8734.182-3.309
YOY2.2555.343-3.088
5Y1.5576.135-4.578
10Y0.8506.453-5.603
1.3.2. Quick Ratio

Measures if Starlake is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Starlake to the Biotechnology industry mean.
  • A Quick Ratio of 0.20 means the company can pay off ¥0.20 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Starlake Bioscience Co Inc Zhaoqing Guangdong:

  • The MRQ is 0.202. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.150. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.202TTM0.150+0.052
TTM0.150YOY0.607-0.457
TTM0.1505Y0.410-0.260
5Y0.41010Y0.421-0.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2023.528-3.326
TTM0.1504.059-3.909
YOY0.6075.390-4.783
5Y0.4106.138-5.728
10Y0.4216.488-6.067

1.4. Solvency of Starlake Bioscience Co Inc Zhaoqing Guangdong.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Starlake assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Starlake to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.46 means that Starlake assets are financed with 45.8% credit (debt) and the remaining percentage (100% - 45.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Starlake Bioscience Co Inc Zhaoqing Guangdong:

  • The MRQ is 0.458. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.528. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.458TTM0.528-0.069
TTM0.528YOY0.263+0.264
TTM0.5285Y0.338+0.190
5Y0.33810Y0.364-0.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4580.339+0.119
TTM0.5280.337+0.191
YOY0.2630.273-0.010
5Y0.3380.368-0.030
10Y0.3640.391-0.027
1.4.2. Debt to Equity Ratio

Measures if Starlake is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Starlake to the Biotechnology industry mean.
  • A Debt to Equity ratio of 85.2% means that company has ¥0.85 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Starlake Bioscience Co Inc Zhaoqing Guangdong:

  • The MRQ is 0.852. The company is very able to pay all its debts with equity. +2
  • The TTM is 1.146. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ0.852TTM1.146-0.293
TTM1.146YOY0.358+0.788
TTM1.1465Y0.559+0.586
5Y0.55910Y0.604-0.045
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8520.388+0.464
TTM1.1460.403+0.743
YOY0.3580.342+0.016
5Y0.5590.432+0.127
10Y0.6040.461+0.143

2. Market Valuation of Starlake Bioscience Co Inc Zhaoqing Guangdong

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Starlake generates.

  • Above 15 is considered overpriced but always compare Starlake to the Biotechnology industry mean.
  • A PE ratio of 8.41 means the investor is paying ¥8.41 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Starlake Bioscience Co Inc Zhaoqing Guangdong:

  • The EOD is 9.069. Based on the earnings, the company is underpriced. +1
  • The MRQ is 8.412. Based on the earnings, the company is underpriced. +1
  • The TTM is 14.333. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD9.069MRQ8.412+0.657
MRQ8.412TTM14.333-5.921
TTM14.333YOY81.836-67.503
TTM14.3335Y77.081-62.747
5Y77.08110Y66.723+10.358
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD9.069-2.249+11.318
MRQ8.412-2.553+10.965
TTM14.333-2.669+17.002
YOY81.836-4.107+85.943
5Y77.081-6.247+83.328
10Y66.723-6.499+73.222
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Starlake Bioscience Co Inc Zhaoqing Guangdong:

  • The EOD is 1.935. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 1.795. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.617. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.935MRQ1.795+0.140
MRQ1.795TTM0.617+1.178
TTM0.617YOY50.163-49.546
TTM0.6175Y118.360-117.743
5Y118.36010Y25.106+93.253
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.935-2.858+4.793
MRQ1.795-3.288+5.083
TTM0.617-3.552+4.169
YOY50.163-5.560+55.723
5Y118.360-8.326+126.686
10Y25.106-8.881+33.987
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Starlake is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.17 means the investor is paying ¥1.17 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Starlake Bioscience Co Inc Zhaoqing Guangdong:

  • The EOD is 1.264. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.172. Based on the equity, the company is underpriced. +1
  • The TTM is 1.325. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.264MRQ1.172+0.092
MRQ1.172TTM1.325-0.153
TTM1.325YOY5.725-4.400
TTM1.3255Y4.472-3.147
5Y4.47210Y5.696-1.225
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.2641.929-0.665
MRQ1.1722.090-0.918
TTM1.3252.091-0.766
YOY5.7252.881+2.844
5Y4.4723.545+0.927
10Y5.6963.936+1.760
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Starlake Bioscience Co Inc Zhaoqing Guangdong compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1580.839-81%0.017+815%0.195-19%0.090+75%
Book Value Per Share--4.4794.305+4%1.088+312%1.630+175%1.161+286%
Current Ratio--0.8840.873+1%2.255-61%1.557-43%0.850+4%
Debt To Asset Ratio--0.4580.528-13%0.263+74%0.338+36%0.364+26%
Debt To Equity Ratio--0.8521.146-26%0.358+138%0.559+52%0.604+41%
Dividend Per Share--0.0220.072-69%0.002+856%0.016+37%0.012+86%
Eps--0.1560.146+7%0.022+619%0.045+245%0.025+531%
Free Cash Flow Per Share--0.7310.419+74%0.016+4473%0.085+755%0.047+1469%
Free Cash Flow To Equity Per Share--0.7310.089+725%0.008+9471%0.026+2687%0.013+5392%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.675+48%
Intrinsic Value_10Y_max--48.300--------
Intrinsic Value_10Y_min--18.124--------
Intrinsic Value_1Y_max--1.192--------
Intrinsic Value_1Y_min--0.466--------
Intrinsic Value_3Y_max--6.362--------
Intrinsic Value_3Y_min--2.578--------
Intrinsic Value_5Y_max--14.884--------
Intrinsic Value_5Y_min--5.965--------
Market Cap9403919928.320+7%8722731234.0009457932866.580-8%10334343101.440-16%8544942996.100+2%8114620762.050+7%
Net Profit Margin--0.0580.036+62%0.104-44%0.099-41%0.067-14%
Operating Margin---0.037-100%0.119-100%0.104-100%0.056-100%
Operating Ratio--1.7751.790-1%1.597+11%1.613+10%1.259+41%
Pb Ratio1.264+7%1.1721.325-12%5.725-80%4.472-74%5.696-79%
Pe Ratio9.069+7%8.41214.333-41%81.836-90%77.081-89%66.723-87%
Price Per Share5.660+7%5.2505.693-8%6.220-16%5.143+2%4.884+7%
Price To Free Cash Flow Ratio1.935+7%1.7950.617+191%50.163-96%118.360-98%25.106-93%
Price To Total Gains Ratio31.442+7%29.16436.629-20%-593.715+2136%23.341+25%76.433-62%
Quick Ratio--0.2020.150+35%0.607-67%0.410-51%0.421-52%
Return On Assets--0.0190.016+17%0.015+29%0.015+25%0.009+101%
Return On Equity--0.0350.035+1%0.020+77%0.024+48%0.015+136%
Total Gains Per Share--0.1800.911-80%0.020+820%0.212-15%0.102+76%
Usd Book Value--1027665507.364987830984.879+4%249670616.900+312%373997600.542+175%266485538.885+286%
Usd Book Value Change Per Share--0.0220.116-81%0.002+815%0.027-19%0.012+75%
Usd Book Value Per Share--0.6190.595+4%0.150+312%0.225+175%0.160+286%
Usd Dividend Per Share--0.0030.010-69%0.000+856%0.002+37%0.002+86%
Usd Eps--0.0220.020+7%0.003+619%0.006+245%0.003+531%
Usd Free Cash Flow--167777901.53996221316.274+74%3669075.066+4473%19617739.841+755%9088302.833+1746%
Usd Free Cash Flow Per Share--0.1010.058+74%0.002+4473%0.012+755%0.006+1469%
Usd Free Cash Flow To Equity Per Share--0.1010.012+725%0.001+9471%0.004+2687%0.002+5392%
Usd Market Cap1298681342.101+7%1204609183.4151306140528.875-8%1427172782.309-16%1180056627.761+2%1120629127.239+7%
Usd Price Per Share0.782+7%0.7250.786-8%0.859-16%0.710+2%0.674+7%
Usd Profit--35799831.03533851019.721+6%4975765.744+619%10445704.863+243%5710824.428+527%
Usd Revenue--616230061.6101009241716.959-39%48090569.686+1181%233611884.593+164%130072443.553+374%
Usd Total Gains Per Share--0.0250.126-80%0.003+820%0.029-15%0.014+76%
 EOD+4 -4MRQTTM+22 -13YOY+25 -105Y+23 -1210Y+28 -8

3.2. Fundamental Score

Let's check the fundamental score of Starlake Bioscience Co Inc Zhaoqing Guangdong based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.069
Price to Book Ratio (EOD)Between0-11.264
Net Profit Margin (MRQ)Greater than00.058
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.202
Current Ratio (MRQ)Greater than10.884
Debt to Asset Ratio (MRQ)Less than10.458
Debt to Equity Ratio (MRQ)Less than10.852
Return on Equity (MRQ)Greater than0.150.035
Return on Assets (MRQ)Greater than0.050.019
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Starlake Bioscience Co Inc Zhaoqing Guangdong based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5076.506
Ma 20Greater thanMa 504.551
Ma 50Greater thanMa 1004.369
Ma 100Greater thanMa 2004.466
OpenGreater thanClose5.420
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets13,742,159
Total Liabilities6,300,700
Total Stockholder Equity7,392,474
 As reported
Total Liabilities 6,300,700
Total Stockholder Equity+ 7,392,474
Total Assets = 13,742,159

Assets

Total Assets13,742,159
Total Current Assets4,069,045
Long-term Assets9,673,114
Total Current Assets
Cash And Cash Equivalents 931,919
Short-term Investments 300,955
Net Receivables 628,698
Inventory 1,573,882
Other Current Assets 34,415
Total Current Assets  (as reported)4,069,045
Total Current Assets  (calculated)3,469,869
+/- 599,175
Long-term Assets
Property Plant Equipment 8,647,882
Goodwill 214,938
Intangible Assets 664,695
Long-term Assets Other 74,773
Long-term Assets  (as reported)9,673,114
Long-term Assets  (calculated)9,602,289
+/- 70,826

Liabilities & Shareholders' Equity

Total Current Liabilities4,601,916
Long-term Liabilities1,698,784
Total Stockholder Equity7,392,474
Total Current Liabilities
Short Long Term Debt 1,606,336
Accounts payable 891,750
Other Current Liabilities 127,591
Total Current Liabilities  (as reported)4,601,916
Total Current Liabilities  (calculated)2,625,677
+/- 1,976,239
Long-term Liabilities
Long term Debt 1,336,352
Capital Lease Obligations Min Short Term Debt4,245
Long-term Liabilities  (as reported)1,698,784
Long-term Liabilities  (calculated)1,340,597
+/- 358,187
Total Stockholder Equity
Retained Earnings 1,001,528
Total Stockholder Equity (as reported)7,392,474
Total Stockholder Equity (calculated)1,001,528
+/- 6,390,946
Other
Capital Stock1,661,473
Common Stock Shares Outstanding 1,661,473
Net Debt 2,010,768
Net Invested Capital 10,335,161
Net Working Capital -532,871
Property Plant and Equipment Gross 8,647,882



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
950,238
1,082,929
1,010,165
1,001,552
981,360
968,839
1,010,774
1,023,825
1,050,169
1,069,710
1,078,126
1,171,399
1,108,860
1,232,854
1,264,617
1,304,246
1,278,043
1,308,274
1,292,227
1,364,436
1,404,401
1,424,061
1,395,342
1,409,068
1,424,113
1,439,477
1,493,094
1,349,302
1,384,875
1,345,077
1,351,566
1,356,908
1,363,233
1,319,855
1,371,332
1,497,633
2,104,058
1,929,880
2,000,036
2,307,209
2,394,580
2,792,365
3,242,671
3,422,452
3,319,724
3,303,274
3,351,813
3,332,617
3,369,464
3,402,392
2,573,718
2,603,736
2,555,158
2,535,599
2,193,805
2,255,528
2,192,177
2,192,766
2,087,948
1,843,984
1,810,325
1,862,839
1,746,255
1,710,314
1,678,890
1,771,726
1,447,216
1,448,709
1,421,735
1,396,114
1,411,440
1,445,352
1,874,241
1,928,707
1,988,788
2,116,232
2,171,898
2,337,659
2,406,897
2,421,969
2,464,073
2,545,206
2,469,936
2,473,349
2,401,338
2,438,475
2,505,831
15,998,453
16,571,514
14,712,672
13,742,159
13,742,15914,712,67216,571,51415,998,4532,505,8312,438,4752,401,3382,473,3492,469,9362,545,2062,464,0732,421,9692,406,8972,337,6592,171,8982,116,2321,988,7881,928,7071,874,2411,445,3521,411,4401,396,1141,421,7351,448,7091,447,2161,771,7261,678,8901,710,3141,746,2551,862,8391,810,3251,843,9842,087,9482,192,7662,192,1772,255,5282,193,8052,535,5992,555,1582,603,7362,573,7183,402,3923,369,4643,332,6173,351,8133,303,2743,319,7243,422,4523,242,6712,792,3652,394,5802,307,2092,000,0361,929,8802,104,0581,497,6331,371,3321,319,8551,363,2331,356,9081,351,5661,345,0771,384,8751,349,3021,493,0941,439,4771,424,1131,409,0681,395,3421,424,0611,404,4011,364,4361,292,2271,308,2741,278,0431,304,2461,264,6171,232,8541,108,8601,171,3991,078,1261,069,7101,050,1691,023,8251,010,774968,839981,3601,001,5521,010,1651,082,929950,238
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
451,392
474,147
499,608
635,632
708,421
725,955
791,089
829,716
808,047
775,433
726,024
737,986
848,351
788,607
807,306
779,958
820,029
896,745
5,955,360
6,665,545
4,896,494
4,069,045
4,069,0454,896,4946,665,5455,955,360896,745820,029779,958807,306788,607848,351737,986726,024775,433808,047829,716791,089725,955708,421635,632499,608474,147451,392000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
75,653
73,858
97,680
153,383
224,503
227,245
264,918
285,474
265,210
222,657
232,550
229,398
215,867
219,110
231,033
213,574
190,044
280,999
1,067,611
1,419,106
927,438
931,919
931,919927,4381,419,1061,067,611280,999190,044213,574231,033219,110215,867229,398232,550222,657265,210285,474264,918227,245224,503153,38397,68073,85875,653000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
306,157
0
20,000
300,955
300,95520,0000306,157000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
121,341
110,045
111,862
160,066
152,638
174,999
181,955
147,590
140,758
129,308
151,308
138,523
164,937
126,923
155,902
135,224
122,165
133,443
138,947
119,401
113,815
133,973
127,607
127,908
138,235
160,178
169,760
137,592
163,033
172,577
156,939
139,698
151,590
121,894
147,192
178,975
184,355
205,833
265,390
234,422
202,747
208,487
234,866
154,495
165,393
209,264
202,149
200,958
174,366
279,741
239,656
203,467
227,014
247,020
241,840
253,271
194,317
199,555
177,508
185,765
182,168
201,892
181,380
175,904
152,991
142,282
150,877
107,289
129,446
135,535
147,981
144,813
167,622
128,642
147,964
188,775
226,148
253,301
264,816
218,568
247,602
276,605
262,538
248,778
163,105
223,254
259,968
890,072
515,477
874,400
628,698
628,698874,400515,477890,072259,968223,254163,105248,778262,538276,605247,602218,568264,816253,301226,148188,775147,964128,642167,622144,813147,981135,535129,446107,289150,877142,282152,991175,904181,380201,892182,168185,765177,508199,555194,317253,271241,840247,020227,014203,467239,656279,741174,366200,958202,149209,264165,393154,495234,866208,487202,747234,422265,390205,833184,355178,975147,192121,894151,590139,698156,939172,577163,033137,592169,760160,178138,235127,908127,607133,973113,815119,401138,947133,443122,165135,224155,902126,923164,937138,523151,308129,308140,758147,590181,955174,999152,638160,066111,862110,045121,341
       Other Current Assets 
16,923
15,781
32,214
23,538
11,725
16,472
17,924
45,886
30,825
73,095
88,352
101,562
115,045
143,760
145,334
76,477
69,184
21,715
16,970
49,551
50,191
47,501
52,860
56,032
52,180
36,142
29,506
42,456
60,770
35,341
23,091
10,323
9,412
19,607
14,201
35,928
68,573
137,039
187,903
488,797
536,240
611,429
616,824
366,150
324,418
290,482
336,069
150,021
144,566
122,291
179,288
240,881
198,921
41,799
33,864
23,892
172,672
66,322
148,477
40,336
193,852
39,639
148,719
28,560
188,981
36,587
39,336
17,529
18,074
18,819
22,596
17,143
9,069
7,906
5,747
17,906
16,204
14,435
18,889
29,157
37,262
49,185
45,627
47,968
45,419
18,713
14,388
362,790
43,306
213,395
34,415
34,415213,39543,306362,79014,38818,71345,41947,96845,62749,18537,26229,15718,88914,43516,20417,9065,7477,9069,06917,14322,59618,81918,07417,52939,33636,587188,98128,560148,71939,639193,85240,336148,47766,322172,67223,89233,86441,799198,921240,881179,288122,291144,566150,021336,069290,482324,418366,150616,824611,429536,240488,797187,903137,03968,57335,92814,20119,6079,41210,32323,09135,34160,77042,45629,50636,14252,18056,03252,86047,50150,19149,55116,97021,71569,18476,477145,334143,760115,045101,56288,35273,09530,82545,88617,92416,47211,72523,53832,21415,78116,923
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,238,609
1,220,285
1,262,833
1,325,143
1,342,182
1,529,612
1,631,464
1,695,945
1,726,087
1,696,855
1,681,329
1,666,043
1,621,379
1,618,446
1,609,086
10,043,093
9,905,969
9,816,178
9,673,114
9,673,1149,816,1789,905,96910,043,0931,609,0861,618,4461,621,3791,666,0431,681,3291,696,8551,726,0871,695,9451,631,4641,529,6121,342,1821,325,1431,262,8331,220,2851,238,609000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
384,191
344,039
375,808
375,679
358,388
399,021
412,911
428,286
438,623
434,400
434,348
434,387
415,850
447,543
505,873
659,653
696,244
798,420
756,785
837,005
770,493
845,888
785,849
848,732
802,359
873,507
814,015
791,240
746,090
782,748
751,784
790,692
715,990
751,336
709,088
722,606
672,998
698,275
655,823
701,169
709,832
880,334
1,069,542
1,801,629
1,660,254
1,933,939
1,755,567
2,192,650
1,941,970
2,176,498
1,214,063
1,373,220
1,174,228
1,149,427
1,118,516
1,000,681
969,887
957,492
1,004,765
852,903
834,378
810,139
779,457
773,342
784,416
771,986
765,461
780,213
776,514
772,368
766,236
778,446
833,158
817,217
807,014
929,924
937,798
1,113,836
1,213,651
1,275,849
1,305,781
1,280,730
1,292,363
1,284,493
1,239,560
1,236,539
1,237,070
8,996,585
8,861,404
8,762,515
8,647,882
8,647,8828,762,5158,861,4048,996,5851,237,0701,236,5391,239,5601,284,4931,292,3631,280,7301,305,7811,275,8491,213,6511,113,836937,798929,924807,014817,217833,158778,446766,236772,368776,514780,213765,461771,986784,416773,342779,457810,139834,378852,9031,004,765957,492969,8871,000,6811,118,5161,149,4271,174,2281,373,2201,214,0632,176,4981,941,9702,192,6501,755,5671,933,9391,660,2541,801,6291,069,542880,334709,832701,169655,823698,275672,998722,606709,088751,336715,990790,692751,784782,748746,090791,240814,015873,507802,359848,732785,849845,888770,493837,005756,785798,420696,244659,653505,873447,543415,850434,387434,348434,400438,623428,286412,911399,021358,388375,679375,808344,039384,191
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
197,787
197,787
197,787
197,957
197,957
197,957
197,957
197,957
197,957
197,957
197,957
197,957
197,957
197,957
197,957
214,938
214,938
214,938
214,938
214,938214,938214,938214,938197,957197,957197,957197,957197,957197,957197,957197,957197,957197,957197,957197,957197,787197,787197,787000000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38,995
38,995
38,995
38,995
38,995
38,995
38,995
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000038,99538,99538,99538,99538,99538,99538,995000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
21,176
29,786
35,583
60,765
52,572
60,136
59,825
61,697
61,379
63,335
62,995
75,225
68,151
67,502
66,862
98,487
97,325
32,069
94,992
30,295
90,885
26,988
87,416
30,430
90,009
28,484
85,394
28,682
69,514
26,862
75,521
26,286
97,638
23,752
91,889
21,928
85,769
19,750
87,229
24,654
83,407
22,146
111,698
33,282
271,158
30,443
328,100
18,972
299,853
16,245
163,207
16,915
190,638
188,364
186,090
185,199
183,374
181,548
179,723
167,231
165,482
163,734
124,867
105,044
126,566
125,282
124,023
122,822
121,638
120,463
119,290
118,122
156,253
34,929
151,786
149,122
157,372
167,143
166,190
165,133
162,853
160,589
136,286
134,169
133,617
131,608
129,492
686,337
679,691
672,418
664,695
664,695672,418679,691686,337129,492131,608133,617134,169136,286160,589162,853165,133166,190167,143157,372149,122151,78634,929156,253118,122119,290120,463121,638122,822124,023125,282126,566105,044124,867163,734165,482167,231179,723181,548183,374185,199186,090188,364190,63816,915163,20716,245299,85318,972328,10030,443271,15833,282111,69822,14683,40724,65487,22919,75085,76921,92891,88923,75297,63826,28675,52126,86269,51428,68285,39428,48490,00930,43087,41626,98890,88530,29594,99232,06997,32598,48766,86267,50268,15175,22562,99563,33561,37961,69759,82560,13652,57260,76535,58329,78621,176
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,724
47,486
63,645
5,431
5,890
7,251
10,634
15,063
17,611
15,902
12,874
15,620
16,361
18,738
11,418
83,578
87,524
90,665
74,773
74,77390,66587,52483,57811,41818,73816,36115,62012,87415,90217,61115,06310,6347,2515,8905,43163,64547,48647,724000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
203,679
331,531
236,806
245,970
207,455
174,246
197,823
188,889
197,290
189,468
184,368
266,818
186,917
348,972
373,739
410,863
382,499
433,543
413,175
489,572
524,418
540,518
504,386
516,890
527,888
553,862
603,261
607,286
637,987
589,802
587,763
580,444
568,818
491,553
505,633
477,362
635,487
558,477
570,930
698,073
856,384
885,613
1,371,876
1,620,258
1,522,517
1,515,870
1,609,968
1,698,075
1,805,212
1,846,715
1,129,352
1,138,324
1,148,483
1,214,220
946,228
787,368
778,260
837,556
799,920
795,881
786,335
832,925
682,912
637,904
632,483
740,340
419,177
534,572
499,665
465,421
465,337
488,935
624,668
480,868
496,152
595,948
619,383
733,728
776,784
752,974
760,467
800,184
721,204
697,742
632,886
614,113
642,663
9,069,256
9,509,735
7,533,060
6,300,700
6,300,7007,533,0609,509,7359,069,256642,663614,113632,886697,742721,204800,184760,467752,974776,784733,728619,383595,948496,152480,868624,668488,935465,337465,421499,665534,572419,177740,340632,483637,904682,912832,925786,335795,881799,920837,556778,260787,368946,2281,214,2201,148,4831,138,3241,129,3521,846,7151,805,2121,698,0751,609,9681,515,8701,522,5171,620,2581,371,876885,613856,384698,073570,930558,477635,487477,362505,633491,553568,818580,444587,763589,802637,987607,286603,261553,862527,888516,890504,386540,518524,418489,572413,175433,543382,499410,863373,739348,972186,917266,818184,368189,468197,290188,889197,823174,246207,455245,970236,806331,531203,679
   > Total Current Liabilities 
203,679
286,471
179,535
228,684
171,948
156,959
150,636
171,207
179,607
141,886
136,786
213,030
126,917
148,972
143,739
171,863
113,499
174,543
174,175
250,573
285,419
311,518
310,386
416,614
427,888
433,861
483,261
507,286
537,987
491,801
489,763
483,944
472,318
426,554
440,633
434,862
574,987
533,477
545,930
576,341
589,286
646,919
343,411
423,757
299,366
385,893
478,543
528,354
601,463
699,915
376,431
414,667
425,687
508,986
502,735
360,345
313,195
373,569
337,986
447,242
439,748
489,391
609,809
564,753
537,990
677,596
359,062
388,600
356,422
323,809
325,355
357,042
496,357
344,945
360,058
507,193
530,024
564,740
536,327
554,017
518,816
573,491
475,382
436,314
351,095
347,935
345,936
6,972,311
7,460,102
5,703,414
4,601,916
4,601,9165,703,4147,460,1026,972,311345,936347,935351,095436,314475,382573,491518,816554,017536,327564,740530,024507,193360,058344,945496,357357,042325,355323,809356,422388,600359,062677,596537,990564,753609,809489,391439,748447,242337,986373,569313,195360,345502,735508,986425,687414,667376,431699,915601,463528,354478,543385,893299,366423,757343,411646,919589,286576,341545,930533,477574,987434,862440,633426,554472,318483,944489,763491,801537,987507,286483,261433,861427,888416,614310,386311,518285,419250,573174,175174,543113,499171,863143,739148,972126,917213,030136,786141,886179,607171,207150,636156,959171,948228,684179,535286,471203,679
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,200
6,100
12,200
153,000
151,000
181,000
232,700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000232,700181,000151,000153,00012,2006,1007,200000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,200
6,100
12,200
153,000
151,000
181,000
232,700
276,200
293,700
250,000
167,500
185,756
179,956
149,956
88,956
107,200
80,000
80,000
2,004,206
2,579,507
2,157,780
1,606,336
1,606,3362,157,7802,579,5072,004,20680,00080,000107,20088,956149,956179,956185,756167,500250,000293,700276,200232,700181,000151,000153,00012,2006,1007,200000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
15,698
10,270
18,946
31,451
30,728
17,961
38,425
63,813
51,666
54,326
64,350
102,136
39,474
46,922
17,588
66,863
33,540
63,561
49,791
73,038
72,429
91,316
62,614
77,594
77,335
83,442
62,438
107,318
120,068
118,143
135,036
149,819
88,846
100,331
104,830
100,707
92,804
104,619
106,933
79,248
88,428
88,120
133,202
162,031
118,027
185,269
198,909
231,881
240,569
281,889
182,089
163,011
140,033
89,693
95,095
110,744
121,281
155,964
146,928
118,893
111,075
116,842
104,532
52,703
75,339
69,606
93,401
72,135
105,827
81,949
80,815
66,011
106,060
96,964
77,425
77,622
92,948
91,054
200,003
152,938
192,291
168,541
166,373
105,955
125,544
80,728
106,964
1,845,784
1,803,421
1,367,318
891,750
891,7501,367,3181,803,4211,845,784106,96480,728125,544105,955166,373168,541192,291152,938200,00391,05492,94877,62277,42596,964106,06066,01180,81581,949105,82772,13593,40169,60675,33952,703104,532116,842111,075118,893146,928155,964121,281110,74495,09589,693140,033163,011182,089281,889240,569231,881198,909185,269118,027162,031133,20288,12088,42879,248106,933104,61992,804100,707104,830100,33188,846149,819135,036118,143120,068107,31862,43883,44277,33577,59462,61491,31672,42973,03849,79163,56133,54066,86317,58846,92239,474102,13664,35054,32651,66663,81338,42517,96130,72831,45118,94610,27015,698
       Other Current Liabilities 
72,981
44,201
41,639
55,283
54,220
34,048
37,261
22,444
21,991
29,610
32,486
36,944
38,443
42,050
49,151
30,000
13,959
19,982
28,384
31,535
31,990
29,202
40,967
30,782
37,425
48,985
33,549
27,119
65,613
26,417
24,727
37,125
55,153
77,223
126,803
115,155
211,183
94,858
104,997
88,497
94,587
169,999
68,109
133,206
59,519
3,704
0
0
0
0
0
48,256
47,955
54,893
33,240
49,701
48,714
74,405
51,058
54,606
64,931
76,807
76,997
100,507
55,647
88,724
47,462
76,265
58,395
42,993
52,127
69,704
31,100
21,600
20,500
48,185
57,063
120,495
48,072
97,576
128,352
92,239
53,471
125,872
40,260
70,044
52,539
2,015,363
1,818,597
796,436
127,591
127,591796,4361,818,5972,015,36352,53970,04440,260125,87253,47192,239128,35297,57648,072120,49557,06348,18520,50021,60031,10069,70452,12742,99358,39576,26547,46288,72455,647100,50776,99776,80764,93154,60651,05874,40548,71449,70133,24054,89347,95548,256000003,70459,519133,20668,109169,99994,58788,497104,99794,858211,183115,155126,80377,22355,15337,12524,72726,41765,61327,11933,54948,98537,42530,78240,96729,20231,99031,53528,38419,98213,95930,00049,15142,05038,44336,94432,48629,61021,99122,44437,26134,04854,22055,28341,63944,20172,981
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128,311
135,923
136,094
88,755
89,359
168,987
240,458
198,958
241,650
226,693
245,821
261,428
281,791
266,178
296,726
2,096,944
2,049,632
1,829,646
1,698,784
1,698,7841,829,6462,049,6322,096,944296,726266,178281,791261,428245,821226,693241,650198,958240,458168,98789,35988,755136,094135,923128,311000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
60
1
11,506
11,507
11,507
11,507
12,002
12,003
12,002
12,002
13,208
1,000
1,000
1,000
0
0
0
0
0
0
0
0
1
0
1
0
0
100,000
1
0
0
0
0
0
0
0
0
0
0
1
0
0
47,297
57,585
51,674
53,742
106,709
110,526
79,955
49,402
48,220
47,038
45,855
44,673
43,491
42,078
40,666
39,253
41,341
39,928
38,516
37,104
38,151
36,694
38,944
37,415
41,273
39,643
38,012
36,382
39,394
55,811
63,923
64,094
67,755
68,359
68,627
66,413
42,788
40,571
38,338
36,110
41,587
39,228
38,186
38,040
562,883
0
232,986
0
0232,9860562,88338,04038,18639,22841,58736,11038,33840,57142,78866,41368,62768,35967,75564,09463,92355,81139,39436,38238,01239,64341,27337,41538,94436,69438,15137,10438,51639,92841,34139,25340,66642,07843,49144,67345,85547,03848,22049,40279,955110,526106,70953,74251,67457,58547,29700100000000001100,00000101000000001,0001,0001,00013,20812,00212,00212,00312,00211,50711,50711,50711,5061600
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,767
1,432
1,595
1,159
616
208
646
472
299
126
2,280
2,149
2,018
2,375
2,761
2,965
2,858
2,577
4,451
0
4,988
0
04,98804,4512,5772,8582,9652,7612,3752,0182,1492,2801262994726462086161,1591,5951,4321,767000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
746,559
751,398
770,575
752,375
770,699
791,145
809,300
831,118
848,808
875,983
889,340
902,594
921,151
883,108
890,131
892,808
895,387
874,568
878,898
874,663
879,791
883,369
890,793
892,025
899,045
885,460
889,669
741,893
746,756
755,230
763,819
774,908
793,041
827,078
863,814
999,408
1,425,386
1,314,390
1,377,630
1,536,220
1,466,527
1,812,358
1,778,890
1,712,822
1,706,862
1,646,264
1,595,698
1,498,297
1,433,139
1,430,157
1,451,379
1,472,733
1,414,001
1,328,711
1,254,912
1,475,499
1,421,260
1,362,557
1,295,377
1,048,104
1,023,990
1,029,914
1,063,342
1,072,410
1,046,407
1,031,386
1,028,039
914,137
922,071
930,692
946,102
956,417
1,249,573
1,447,838
1,492,636
1,520,285
1,552,516
1,603,932
1,630,113
1,668,995
1,703,606
1,745,022
1,748,733
1,775,608
1,768,452
1,824,362
1,863,168
6,880,841
7,011,802
7,133,425
7,392,474
7,392,4747,133,4257,011,8026,880,8411,863,1681,824,3621,768,4521,775,6081,748,7331,745,0221,703,6061,668,9951,630,1131,603,9321,552,5161,520,2851,492,6361,447,8381,249,573956,417946,102930,692922,071914,1371,028,0391,031,3861,046,4071,072,4101,063,3421,029,9141,023,9901,048,1041,295,3771,362,5571,421,2601,475,4991,254,9121,328,7111,414,0011,472,7331,451,3791,430,1571,433,1391,498,2971,595,6981,646,2641,706,8621,712,8221,778,8901,812,3581,466,5271,536,2201,377,6301,314,3901,425,386999,408863,814827,078793,041774,908763,819755,230746,756741,893889,669885,460899,045892,025890,793883,369879,791874,663878,898874,568895,387892,808890,131883,108921,151902,594889,340875,983848,808831,118809,300791,145770,699752,375770,575751,398746,559
   Common Stock
192,715
250,530
325,689
325,689
325,689
325,689
325,689
325,689
325,689
325,689
325,689
325,689
325,689
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
521,103
550,393
550,393
550,393
550,393
550,393
550,393
550,393
550,393
550,393
550,393
550,393
550,394
550,394
550,394
645,394
645,394
645,394
645,394
645,394
645,394
645,394
645,394
645,394
645,394
645,394
645,394
645,394
645,394
645,393
645,393
645,393
700,947
739,019
739,019
739,019
739,019
739,019
739,019
739,019
739,019
739,019
739,019
739,019
739,019
739,019
739,019
1,661,473
0
1,661,473
0
01,661,47301,661,473739,019739,019739,019739,019739,019739,019739,019739,019739,019739,019739,019739,019739,019739,019700,947645,393645,393645,393645,394645,394645,394645,394645,394645,394645,394645,394645,394645,394645,394645,394645,394645,394550,394550,394550,394550,393550,393550,393550,393550,393550,393550,393550,393550,393550,393550,393521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103521,103325,689325,689325,689325,689325,689325,689325,689325,689325,689325,689325,689250,530192,715
   Retained Earnings 
102,008
93,872
40,041
14,667
32,991
53,437
71,592
81,536
99,226
126,401
139,757
91,915
110,472
88,714
95,737
67,978
70,557
75,793
80,123
79,660
84,788
88,366
95,790
79,576
101,991
88,406
92,615
0
0
0
0
0
0
29,415
66,151
180,277
200,198
272,424
332,554
358,381
399,953
469,033
473,149
436,920
410,968
382,861
337,361
234,071
177,751
181,963
193,353
251,887
367,384
275,437
200,035
63,944
14,678
0
0
0
0
0
0
0
0
0
0
0
0
-475,822
-460,412
-450,097
-585,899
-545,849
-501,051
-300,545
-268,314
-216,898
-190,717
-151,835
-117,224
-75,808
-72,237
-45,365
-52,451
3,083
41,894
528,698
627,606
758,867
1,001,528
1,001,528758,867627,606528,69841,8943,083-52,451-45,365-72,237-75,808-117,224-151,835-190,717-216,898-268,314-300,545-501,051-545,849-585,899-450,097-460,412-475,82200000000000014,67863,944200,035275,437367,384251,887193,353181,963177,751234,071337,361382,861410,968436,920473,149469,033399,953358,381332,554272,424200,198180,27766,15129,41500000092,61588,406101,99179,57695,79088,36684,78879,66080,12375,79370,55767,97895,73788,714110,47291,915139,757126,40199,22681,53671,59253,43732,99114,66740,04193,872102,008
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
140
143
73
449
444
2,872
0
73,560
0
073,56002,872444449731431400000000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue17,342,695
Cost of Revenue-15,033,948
Gross Profit2,308,7472,308,747
 
Operating Income (+$)
Gross Profit2,308,747
Operating Expense-16,198,164
Operating Income1,144,531-13,889,417
 
Operating Expense (+$)
Research Development193,230
Selling General Administrative324,646
Selling And Marketing Expenses-
Operating Expense16,198,164517,875
 
Net Interest Income (+$)
Interest Income11,630
Interest Expense-211,498
Other Finance Cost-6,122
Net Interest Income-205,990
 
Pretax Income (+$)
Operating Income1,144,531
Net Interest Income-205,990
Other Non-Operating Income Expenses-
Income Before Tax (EBT)834,2221,144,531
EBIT - interestExpense = -211,498
597,540
809,038
Interest Expense211,498
Earnings Before Interest and Taxes (EBIT)-1,045,720
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax834,222
Tax Provision-150,253
Net Income From Continuing Ops683,969683,969
Net Income597,540
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-205,990
 

Technical Analysis of Starlake
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Starlake. The general trend of Starlake is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Starlake's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Starlake Bioscience Co Inc Zhaoqing Guangdong.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 5.78 < 5.85 < 5.9.

The bearish price targets are: 5.48 > 5.46 > 5.38.

Tweet this
Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Starlake Bioscience Co Inc Zhaoqing Guangdong. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Starlake Bioscience Co Inc Zhaoqing Guangdong. The current macd is 0.27102376.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Starlake price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Starlake. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Starlake price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Moving Average Convergence/Divergence (MACD) ChartStarlake Bioscience Co Inc Zhaoqing Guangdong Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Starlake Bioscience Co Inc Zhaoqing Guangdong. The current adx is 29.80.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Starlake shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Starlake Bioscience Co Inc Zhaoqing Guangdong. The current sar is 4.28786824.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Starlake Bioscience Co Inc Zhaoqing Guangdong. The current rsi is 76.51. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Relative Strength Index (RSI) ChartStarlake Bioscience Co Inc Zhaoqing Guangdong Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Starlake Bioscience Co Inc Zhaoqing Guangdong. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Starlake price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Stochastic Oscillator ChartStarlake Bioscience Co Inc Zhaoqing Guangdong Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Starlake Bioscience Co Inc Zhaoqing Guangdong. The current cci is 190.43.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Commodity Channel Index (CCI) ChartStarlake Bioscience Co Inc Zhaoqing Guangdong Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Starlake Bioscience Co Inc Zhaoqing Guangdong. The current cmo is 62.22.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Chande Momentum Oscillator (CMO) ChartStarlake Bioscience Co Inc Zhaoqing Guangdong Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Starlake Bioscience Co Inc Zhaoqing Guangdong. The current willr is -7.960199.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Williams %R ChartStarlake Bioscience Co Inc Zhaoqing Guangdong Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Starlake Bioscience Co Inc Zhaoqing Guangdong.

Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Starlake Bioscience Co Inc Zhaoqing Guangdong. The current atr is 0.22906662.

Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Average True Range (ATR) ChartStarlake Bioscience Co Inc Zhaoqing Guangdong Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Starlake Bioscience Co Inc Zhaoqing Guangdong. The current obv is 292,101,528.

Starlake Bioscience Co Inc Zhaoqing Guangdong Daily On-Balance Volume (OBV) ChartStarlake Bioscience Co Inc Zhaoqing Guangdong Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Starlake Bioscience Co Inc Zhaoqing Guangdong. The current mfi is 85.24.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Money Flow Index (MFI) ChartStarlake Bioscience Co Inc Zhaoqing Guangdong Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Starlake Bioscience Co Inc Zhaoqing Guangdong.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Starlake Bioscience Co Inc Zhaoqing Guangdong Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Starlake Bioscience Co Inc Zhaoqing Guangdong based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5076.506
Ma 20Greater thanMa 504.551
Ma 50Greater thanMa 1004.369
Ma 100Greater thanMa 2004.466
OpenGreater thanClose5.420
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Starlake with someone you think should read this too:
  • Are you bullish or bearish on Starlake? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Starlake? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Starlake Bioscience Co Inc Zhaoqing Guangdong

I send you an email if I find something interesting about Starlake Bioscience Co Inc Zhaoqing Guangdong.


Comments

How you think about this?

Leave a comment

Stay informed about Starlake Bioscience Co Inc Zhaoqing Guangdong.

Receive notifications about Starlake Bioscience Co Inc Zhaoqing Guangdong in your mailbox!